Robert Maldonado, MD
Physical Medicine & Rehabilitation · Atlanta, GANPI 1205332806
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,509 of the $3,767 with a category attached, or 66.6%. 6 manufacturers reported payments, led by Stryker at 42.7% of the total. Reporting peaked in 2024 at $2,471 and has fallen 90.9% since, to $224 in 2025.
Across 32 payments — averaging $117.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medtronic$2K
- SPR Therapeutics, Inc$252
- Boston Scientific$171
- Nalu Medical, Inc.$144
- Bioventus LLC$16
What the payments were for
- Travel & lodging$2,50967%
- Food & beverage$1,25833%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 7 | $1,608 |
| Medtronic | 15 | $1,575 |
| SPR Therapeutics, Inc | 5 | $252 |
| Boston Scientific | 3 | $171 |
| Nalu Medical, Inc. | 1 | $144 |
| Bioventus LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,767 in reported general payments places this provider in the 85th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 21 | $6,459 |
| Fentanyl | 58 | $4,965 |
| Gabapentin | 230 | $3,546 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 191 | $3,443 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 168 | $3,190 |
| Pregabalin | 115 | $1,797 |
| Baclofen | 96 | $1,167 |
| Methocarbamol | 82 | $1,007 |
| Tizanidine Hcl | 73 | $774 |
| Morphine Sulfate ErMorphine Sulfate | 42 | $600 |
| Tramadol Hcl | 106 | $598 |
| Diclofenac Sodium | 36 | $355 |
| Duloxetine Hcl | 27 | $294 |
| Meclizine Hcl | 11 | $114 |
| Oxycodone Hcl | 14 | $110 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Atlanta
- Erik ShawAtlanta$175K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald BilskyAtlanta$16K
- Malcolm CarsonAtlanta$9K
- Michael ChuAtlanta$7K
- Michael YochelsonAtlanta$7K
- Derick DavisAtlanta$6K
- Ashish KhannaAtlanta$6K
- Robert GodsallAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.